Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]

Lu Y, Liu ZH, Li YX, Xu HL, Fang WH, He F. Int J Nanomedicine. 2022;17:1593—1608. We, the Publisher and Editor of International Journal of Nanomedicine, are issuing an expression of concern for the published article. Following publication, concerns regarding the integrity of Figure 2A in...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Y, Liu ZH, Li YX, Xu HL, Fang WH, He F
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/eoc--peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592082890391552
author Lu Y
Liu ZH
Li YX
Xu HL
Fang WH
He F
author_facet Lu Y
Liu ZH
Li YX
Xu HL
Fang WH
He F
author_sort Lu Y
collection DOAJ
description Lu Y, Liu ZH, Li YX, Xu HL, Fang WH, He F. Int J Nanomedicine. 2022;17:1593—1608. We, the Publisher and Editor of International Journal of Nanomedicine, are issuing an expression of concern for the published article. Following publication, concerns regarding the integrity of Figure 2A in the article were brought to the Journal’s attention. As part of the investigation, the authors were contacted for any information that would help confirm the validity of Figure 2A. Whilst the authors were cooperative, the concerns with Figure 2A still remain. Therefore, we are unable to fully address the concerns regarding Figure 2A; however, the Editor confirms that the concerns raised about figure 2A do not affect the overall validity or integrity of the reported findings. We advise readers to interpret the information presented in Figure 2A with due caution. The authors have been notified about this Expression of Concern. Should further information come to light, the journal will reassess any concern raised.
format Article
id doaj-art-accf300870e04d6fa2f2a8f74fa90b69
institution Kabale University
issn 1178-2013
language English
publishDate 2025-01-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj-art-accf300870e04d6fa2f2a8f74fa90b692025-01-21T16:58:06ZengDove Medical PressInternational Journal of Nanomedicine1178-20132025-01-01Volume 2096796899464Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]Lu YLiu ZHLi YXXu HLFang WHHe FLu Y, Liu ZH, Li YX, Xu HL, Fang WH, He F. Int J Nanomedicine. 2022;17:1593—1608. We, the Publisher and Editor of International Journal of Nanomedicine, are issuing an expression of concern for the published article. Following publication, concerns regarding the integrity of Figure 2A in the article were brought to the Journal’s attention. As part of the investigation, the authors were contacted for any information that would help confirm the validity of Figure 2A. Whilst the authors were cooperative, the concerns with Figure 2A still remain. Therefore, we are unable to fully address the concerns regarding Figure 2A; however, the Editor confirms that the concerns raised about figure 2A do not affect the overall validity or integrity of the reported findings. We advise readers to interpret the information presented in Figure 2A with due caution. The authors have been notified about this Expression of Concern. Should further information come to light, the journal will reassess any concern raised.https://www.dovepress.com/eoc--peer-reviewed-fulltext-article-IJNdendritic cell targeted deliveryself-assembling peptide-based nanoparticlesvirus-like particlesnanovaccineenhanced immunogenicity
spellingShingle Lu Y
Liu ZH
Li YX
Xu HL
Fang WH
He F
Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
International Journal of Nanomedicine
dendritic cell targeted delivery
self-assembling peptide-based nanoparticles
virus-like particles
nanovaccine
enhanced immunogenicity
title Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
title_full Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
title_fullStr Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
title_full_unstemmed Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
title_short Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo [Expression of Concern]
title_sort targeted delivery of nanovaccine to dendritic cells via dc binding peptides induces potent antiviral immunity in vivo expression of concern
topic dendritic cell targeted delivery
self-assembling peptide-based nanoparticles
virus-like particles
nanovaccine
enhanced immunogenicity
url https://www.dovepress.com/eoc--peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT luy targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern
AT liuzh targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern
AT liyx targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern
AT xuhl targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern
AT fangwh targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern
AT hef targeteddeliveryofnanovaccinetodendriticcellsviadcbindingpeptidesinducespotentantiviralimmunityinvivoexpressionofconcern